Summary
Welcome to the seventeenth edition of the rare disease newsletter. A few months has changed the world of clinical research into a very different place. This issue includes a summary of work PRA has done to understand the impact of COVID19 on the rare disease patient community and to rare disease research.
Register to download
RARE DISEASES NEWSLETTER Volume 17, July 2020
You may also be interested in:

Ask the Experts: What Does the Future Hold for CRISPR Gene Editing Technology?
Changing a living organism’s DNA sounds like something out of science fiction, but recent strides in genome (gene) editing have given scientists…
Read Story

Rare Diseases Advisory Committee Members
Read More

The True Cost of Ineffective Clinical Trials
The process of designing and implementing clinical trials hasn’t changed much over the decades — which may be why 1 in 5 clinical trials fail due to…
View Resource
View all related content and resources for Rare Disease
Explore Insights